Protective immunity induced by live attenuated simian immunodeficiency virus (Q45753990)

15 December 2017

review article

1 reference

title

Protective immunity induced by live attenuated simian immunodeficiency virus (English)

1 reference

15 December 2017

Simian immunodeficiency virus

main subject

0 references

1 reference

Johnson RP

1 reference

15 December 2017

Desrosiers RC

series ordinal

1 reference

15 December 2017

publication date

1 August 1998

1 reference

15 December 2017

Current Opinion in Immunology

published in

1 reference

15 December 2017

volume

1 reference

15 December 2017

issue

1 reference

15 December 2017

page(s)

436-443

1 reference

15 December 2017

Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Immune responses in HIV-exposed seronegatives: have they repelled the virus?

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Toward an understanding of the correlates of protective immunity to HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Studies in subjects with long-term nonprogressive human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

The simian immunodeficiency viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Vaccine protection by a triple deletion mutant of simian immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Importance of the nef gene for maintenance of high virus loads and for development of AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Protection against mucosal SIVsm challenge in macaques infected with a chimeric SIV that expresses HIV type 1 envelope

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Infection of cynomolgus monkeys with HIV-2 protects against pathogenic consequences of a subsequent simian immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

A minimally replicative HIV-2 live-virus vaccine protects M. nemestrina from disease after HIV-2(287) challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

A vaccine for HIV type 1: The antibody perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Protection from pathogenic SIVmac challenge following short-term infection with a nef-deficient attenuated virus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Induction of AIDS by simian immunodeficiency virus lacking NF-kappaB and SP1 binding elements

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Inhibition of simian immunodeficiency virus (SIV) replication by CD8(+) T lymphocytes from macaques immunized with live attenuated SIV

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Mechanisms of protection induced by attenuated simian immunodeficiency virus. I. Protection cannot be transferred with immune serum.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Role of Cellular Immunity in Protection against HIV Infection**This article was accepted for publication on 31 October 1996

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Cytotoxic T-cell response and AIDS-free survival in simian immunodeficiency virus-infected macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

High-titer immune responses elicited by recombinant vaccinia virus priming and particle boosting are ineffective in preventing virulent SIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Simian immunodeficiency virus DNA vaccine trial in macaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Protection of human immunodeficiency virus type 2-exposed seronegative macaques from mucosal simian immunodeficiency virus transmission.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

A caution on the use of SIV/HIV gag antigen detection systems in neutralization assays

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980118-0

7 January 2021

10.1016/S0952-7915(98)80118-0

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017